+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Extracorporeal Shock Wave Lithotripsy Market - Global Forecast 2026-2032- Product Image
Extracorporeal Shock Wave Lithotripsy Market - Global Forecast 2026-2032- Product Image
Sale

Extracorporeal Shock Wave Lithotripsy Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • July 2026
  • Region: Global
  • 360iResearch™
  • ID: 5715814
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Extracorporeal Shock Wave Lithotripsy Market is projected to reach USD 410.24 Million in 2026. It is expected to continue growing at a CAGR of 6.69%, reaching USD 602.68 Million by 2032.

Extracorporeal shock wave lithotripsy (ESWL) remains a cornerstone non-invasive treatment for urinary stone disease, particularly renal and upper ureteral calculi that are suitable by size, location, composition, and patient anatomy. The procedure uses externally generated acoustic shock waves focused on stones to fragment them into passable particles, reducing the need for incisions and supporting same-day care in many settings. Clinical adoption is closely tied to the global burden of urolithiasis, which is associated with low fluid intake, dehydration, dietary sodium intake, obesity, metabolic syndrome, recurrent urinary tract infections, and climate-related heat exposure. Current practice emphasizes appropriate patient selection, imaging-based stone characterization, radiation-conscious workflows, and post-procedure follow-up to confirm stone clearance and manage recurrence risk. As healthcare systems prioritize minimally invasive urology, ESWL continues to be evaluated alongside ureteroscopy and percutaneous nephrolithotomy based on stone-free outcomes, retreatment rates, anesthesia requirements, complication profiles, patient preference, and total care pathway efficiency.

Transformative Shifts in the ESWL Landscape

The ESWL landscape is being reshaped by a stronger focus on precision targeting, patient-centered care, and evidence-based procedure selection. Modern systems increasingly integrate ultrasound and fluoroscopic guidance to improve stone localization while helping clinicians limit radiation exposure where feasible. Urology guidelines continue to refine indications by stone burden, lower pole anatomy, skin-to-stone distance, stone density on computed tomography, and suspected composition, all of which influence fragmentation success. Operationally, ambulatory surgery centers and outpatient hospital departments are expanding the role of ESWL where reimbursement, trained staffing, and device access support efficient throughput. At the same time, ureteroscopy has gained preference for certain stone profiles due to immediate visual treatment and higher single-session clearance in selected cases, placing pressure on ESWL providers to demonstrate optimized protocols, reduced retreatment, and better patient stratification. The shift is therefore not away from ESWL, but toward more disciplined use in cases where non-invasive kidney stone treatment offers meaningful clinical and economic advantages.

Cumulative Impact of Artificial Intelligence on ESWL

Artificial intelligence is beginning to influence ESWL through image interpretation, treatment planning, and clinical decision support rather than replacing clinician judgment. AI-enabled imaging tools can support automated stone detection, volumetric assessment, and Hounsfield unit evaluation on computed tomography, helping estimate fragmentation likelihood and guide modality selection. Machine learning models are also being investigated to predict ESWL success using variables such as stone size, location, density, skin-to-stone distance, body mass index, hydronephrosis, and prior stone history. In procedural settings, AI-assisted targeting and motion-compensation concepts may help address respiratory movement and improve energy delivery consistency, although broad clinical validation and workflow integration remain essential. Beyond the procedure, predictive analytics can help identify patients at elevated risk of recurrence, prompting metabolic evaluation, hydration counseling, dietary modification, and pharmacologic prevention when clinically indicated. The cumulative impact of artificial intelligence is expected to be strongest where it improves patient selection, standardizes imaging interpretation, reduces avoidable procedures, and supports measurable outcomes in kidney stone management.

Key Regional Insights Across Global ESWL Adoption

Asia-Pacific is a high-priority region for ESWL because populous countries face rising kidney stone incidence linked to urbanization, dietary sodium intake, diabetes, obesity, and hot climates that increase dehydration risk. In North America, established urology infrastructure, broad access to computed tomography and ultrasound imaging, and mature outpatient care pathways support continued use of ESWL for appropriately selected stones, while clinical practice increasingly compares outcomes with ureteroscopy. Latin America shows demand tied to improving specialty care access and the need for cost-conscious, minimally invasive treatment, although availability may vary between major urban hospitals and underserved regions. Europe benefits from standardized clinical guidelines, strong emphasis on radiation protection, and integrated stone centers that use ESWL within a multimodal urology framework. The Middle East presents sustained procedural relevance due to hot weather, dehydration exposure, and a recognized stone disease burden, with advanced hospitals investing in non-invasive and endoscopic urology. Africa remains heterogeneous, with ESWL access concentrated in larger referral centers and opportunities linked to diagnostic capacity, workforce training, device maintenance, and broader access to safe kidney stone disease treatment.

Key Group Insights Shaping ESWL Demand

ASEAN demand for ESWL is influenced by growing urban healthcare capacity, expanding private hospital networks, and climatic conditions that can contribute to recurrent stone formation, with adoption strongest where imaging and urology specialist access are concentrated. GCC countries show a clear clinical need for kidney stone interventions due to heat exposure, dehydration risk, and high prevalence of metabolic conditions, supporting investment in advanced urology services and outpatient treatment models. The European Union provides a highly regulated environment shaped by device safety standards, clinical guideline adherence, and radiation-dose management, encouraging structured ESWL use within evidence-based care pathways. BRICS countries combine large patient populations with uneven healthcare access, creating opportunities for scalable non-invasive stone treatment while underscoring the importance of affordability, maintenance infrastructure, and specialist training. G7 countries are characterized by sophisticated urology networks, aging populations, advanced imaging availability, and strong scrutiny of comparative effectiveness between ESWL and endourological alternatives. NATO member countries, many of which overlap with high-income healthcare systems, generally emphasize resilient hospital infrastructure, technology-enabled care delivery, and standardized clinical practices, supporting ESWL use where clinical indications and reimbursement frameworks align.

Key Country Insights for ESWL Care Pathways

The United States has a well-established kidney stone treatment ecosystem, with ESWL used in hospitals and outpatient settings alongside ureteroscopy and percutaneous procedures, guided by clinical guidelines and payer scrutiny of repeat interventions. Canada emphasizes evidence-based specialty care and access through regional health systems, with ESWL availability often tied to hospital-based urology programs. Mexico and Brazil show increasing need for minimally invasive stone management as urban centers expand specialist services, while access gaps remain in rural and lower-resource areas. The United Kingdom, Germany, France, Italy, and Spain integrate ESWL within guideline-driven urology pathways, supported by diagnostic imaging, referral networks, and quality-focused public or mixed healthcare systems; Germany and France also demonstrate strong procedural standardization in specialist environments. Russia presents a large geographic care-delivery challenge, making regional availability and referral infrastructure important for ESWL access. China and India face substantial kidney stone burdens due to population scale, dietary transitions, and climate-related dehydration in many regions, with leading hospitals using advanced stone management while broader access depends on equipment distribution and trained personnel. Japan and South Korea combine advanced imaging, aging populations, and high clinical technology adoption, supporting precision-oriented ESWL use. Australia applies ESWL within a developed urology system where patient geography, referral pathways, and access to regional specialist centers influence treatment delivery.

Actionable Recommendations for ESWL Industry Leaders

Industry leaders should prioritize clinically validated patient-selection tools that improve ESWL success rates and reduce unnecessary retreatment. Investment in imaging integration, ultrasound-guided workflows, dose-conscious fluoroscopy, and user-friendly targeting interfaces can strengthen procedural efficiency and safety. Providers should develop standardized protocols covering stone assessment, analgesia, energy escalation, shock rate, follow-up imaging, and recurrence prevention counseling. Device manufacturers and service partners should emphasize uptime, preventive maintenance, training, and lifecycle support, particularly in regions where equipment reliability determines access. Healthcare organizations can improve outcomes by embedding ESWL into multidisciplinary stone clinics that include metabolic evaluation, nutrition guidance, hydration counseling, and long-term prevention. Stakeholders should also generate real-world evidence comparing ESWL outcomes by stone density, location, burden, and patient anatomy, ensuring that positioning remains grounded in measurable clinical value rather than procedure volume alone.

Research Methodology for ESWL Insights

This executive summary is developed using a secondary research approach grounded in publicly available, clinically credible, and regulatory-relevant sources. Inputs include urology association guidelines, peer-reviewed medical literature, public health data on urolithiasis risk factors, device safety frameworks, hospital care pathway documentation, and regional healthcare infrastructure indicators. The analysis excludes market sizing, revenue estimation, market share ranking, and forecasting, focusing instead on clinical adoption drivers, technology shifts, regional access patterns, and evidence-based decision factors. Insights are synthesized through triangulation of disease burden indicators, treatment guideline recommendations, imaging and procedural standards, and healthcare delivery characteristics. Emphasis is placed on verified themes such as minimally invasive stone treatment, ESWL patient selection, artificial intelligence in medical imaging, outpatient urology workflows, radiation reduction, and recurrence prevention in kidney stone disease.

Conclusion: ESWL’s Role in Modern Stone Management

Extracorporeal shock wave lithotripsy continues to play an important role in kidney stone treatment where stone characteristics, patient anatomy, and care setting support non-invasive fragmentation. Its future competitiveness depends on precision selection, reliable imaging guidance, optimized treatment protocols, and integration with broader stone prevention strategies. Artificial intelligence, advanced imaging analytics, and standardized outpatient workflows can enhance the value of ESWL by improving procedural planning and reducing variability. Regional and country-level adoption will remain shaped by urology infrastructure, climate-related stone risk, reimbursement models, equipment access, and trained specialist availability. For healthcare leaders, the strategic priority is to position ESWL not as a universal solution, but as a high-value option within an evidence-based continuum of urinary stone disease management.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Extracorporeal Shock Wave Lithotripsy Market, by Technology
7.1. Introduction
7.2. Electrohydraulic
7.3. Electromagnetic
7.4. Piezoelectric
8. Extracorporeal Shock Wave Lithotripsy Market, by Portability
8.1. Introduction
8.2. Mobile
8.3. Stationary
9. Extracorporeal Shock Wave Lithotripsy Market, by Treatment Mode
9.1. Introduction
9.2. Inpatient
9.3. Outpatient
10. Extracorporeal Shock Wave Lithotripsy Market, by Application
10.1. Introduction
10.2. Gallbladder Stones
10.3. Renal Calculi
10.4. Ureteral Calculi
11. Extracorporeal Shock Wave Lithotripsy Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.2.1. Freestanding Centers
11.2.2. Hospital Based Centers
11.3. Clinics
11.3.1. Multispecialty Clinics
11.3.2. Urology Clinics
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Extracorporeal Shock Wave Lithotripsy Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Extracorporeal Shock Wave Lithotripsy Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Extracorporeal Shock Wave Lithotripsy Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Allengers Medical Systems
16.2. ARI Medical Technology Co., Ltd.
16.3. Dornier MedTech GmbH
16.4. EDAP TMS SA
16.5. ELMED Medical Systems
16.6. Elvation Medical
16.7. EMS Electro Medical Systems SA
16.8. GEMSS Co., Ltd.
16.9. Inceler Medikal Ltd.
16.10. Likamed GmbH
16.11. Medispec
16.12. MTS Medical AG
16.13. Nanjing Kapu Technology Co., Ltd.
16.14. Northern Litho, Inc.
16.15. Olympus Corporation
16.16. PT LUMINA PROCARE MEDITECH
16.17. Richard Wolf GmbH.
16.18. Shenzhen Hyde Medical Equipment
16.19. Shenzhen Wikkon Precision Technologies Co., Ltd.
16.20. Siemens Healthineers AG
16.21. Storz Medical AG
16.22. The Direx Group
16.23. United Medical Systems Inc.
16.24. Zimmer MedizinSysteme GmbH
List of Figures
FIGURE 1. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 7. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ELECTROHYDRAULIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ELECTROHYDRAULIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ELECTROHYDRAULIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ELECTROMAGNETIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ELECTROMAGNETIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ELECTROMAGNETIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PIEZOELECTRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PIEZOELECTRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PIEZOELECTRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MOBILE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MOBILE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MOBILE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL STATIONARY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL STATIONARY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL STATIONARY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL INPATIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL INPATIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL INPATIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL OUTPATIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL OUTPATIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL OUTPATIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GALLBLADDER STONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GALLBLADDER STONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GALLBLADDER STONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL RENAL CALCULI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL RENAL CALCULI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL RENAL CALCULI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL URETERAL CALCULI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL URETERAL CALCULI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL URETERAL CALCULI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL FREESTANDING CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL FREESTANDING CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL FREESTANDING CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HOSPITAL BASED CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HOSPITAL BASED CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HOSPITAL BASED CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MULTISPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MULTISPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MULTISPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL UROLOGY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL UROLOGY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL UROLOGY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 68. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 69. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 70. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 71. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 72. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 73. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 74. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 93. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 95. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 96. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 97. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 98. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 100. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 101. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 106. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 111. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 113. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 114. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 115. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 118. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 119. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 123. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 124. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 125. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 126. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 128. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 129. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 130. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 133. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 134. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 137. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 138. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 148. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 150. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 151. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 152. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 155. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 156. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 157. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 159. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 160. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 161. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 164. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 165. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 166. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 168. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 169. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 170. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 173. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 174. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 177. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 180. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 183. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 185. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 186. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 187. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 188. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 189. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 192. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 193. CANADA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 194. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 195. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 196. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 197. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 198. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 201. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 202. MEXICO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 203. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 204. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 205. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 206. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 207. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 210. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 211. BRAZIL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 212. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 213. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 214. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 215. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 216. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 217. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 219. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 220. UNITED KINGDOM EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 221. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 222. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 224. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 225. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 226. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 228. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 229. GERMANY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 230. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 231. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 232. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 233. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 234. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 235. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 237. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 238. FRANCE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 239. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 240. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 241. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 242. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 243. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 246. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 247. RUSSIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 248. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 249. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 250. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 251. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 252. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 253. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 254. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 255. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 256. ITALY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 257. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 258. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 259. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 260. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 261. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 262. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 263. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 264. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 265. SPAIN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 266. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 267. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 268. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 269. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 270. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 271. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 272. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 273. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 274. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 275. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 276. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 277. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 278. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 279. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 280. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 281. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 282. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 283. INDIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 284. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 285. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 286. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 287. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 288. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 289. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 290. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 291. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 292. JAPAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 293. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 294. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 295. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 296. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 297. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 298. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 299. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 300. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 301. AUSTRALIA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 302. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 303. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 304. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 305. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
TABLE 306. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 307. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 308. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 309. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 310. SOUTH KOREA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 311. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SHARE, BY KEY PLAYER, 2025
TABLE 312. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Allengers Medical Systems
  • ARI Medical Technology Co., Ltd.
  • Dornier MedTech GmbH
  • EDAP TMS SA
  • ELMED Medical Systems
  • Elvation Medical
  • EMS Electro Medical Systems SA
  • GEMSS Co., Ltd.
  • Inceler Medikal Ltd.
  • Likamed GmbH
  • Medispec
  • MTS Medical AG
  • Nanjing Kapu Technology Co., Ltd.
  • Northern Litho, Inc.
  • Olympus Corporation
  • PT LUMINA PROCARE MEDITECH
  • Richard Wolf GmbH.
  • Shenzhen Hyde Medical Equipment
  • Shenzhen Wikkon Precision Technologies Co., Ltd.
  • Siemens Healthineers AG
  • Storz Medical AG
  • The Direx Group
  • United Medical Systems Inc.
  • Zimmer MedizinSysteme GmbH

Table Information

Report AttributeDetails
No. of Pages192
PublishedJuly 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 410.24 Million
Forecasted Market Value ( USD ) by 2032 $ 602.68 Million
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Extracorporeal Shock Wave Lithotripsy - Global Strategic Business Report - Product Image

Extracorporeal Shock Wave Lithotripsy - Global Strategic Business Report

  • Report
  • 374 Pages
  • Global
From
Extracorporeal Shock Wave Lithotripsy Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology (Electromagnetic, Electrohydraulic, Piezoelectric), Application, End User - Product Image

Extracorporeal Shock Wave Lithotripsy Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology (Electromagnetic, Electrohydraulic, Piezoelectric), Application, End User

  • Report
  • 160 Pages
  • Global
From
Urolithiasis Management Devices - Global Strategic Business Report - Product Image

Urolithiasis Management Devices - Global Strategic Business Report

  • Report
  • 279 Pages
  • Global
From
Lithotripsy Devices Market by Product Type, Mode, Imaging Type, Application, End User - Global Forecast 2026-2032 - Product Image

Lithotripsy Devices Market by Product Type, Mode, Imaging Type, Application, End User - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Lithotripters Market Size, Share, Trends and Forecast by Device, Application, End User, and Region, 2026-2034 - Product Image

Lithotripters Market Size, Share, Trends and Forecast by Device, Application, End User, and Region, 2026-2034

  • Report
  • 142 Pages
  • Global
From

About the Extracorporeal Shock Wave Lithotripsy Market

Extracorporeal Shock Wave Lithotripsy (ESWL) is a minimally invasive surgical procedure used to treat kidney stones. It uses shock waves to break up stones into smaller pieces that can be passed naturally. The procedure is performed under general anesthesia and typically takes less than an hour. The patient is placed on a water-filled cushion and shock waves are directed at the stone from outside the body. The ESWL market is growing due to the increasing prevalence of kidney stones and the growing demand for minimally invasive treatments. The procedure is also cost-effective and has fewer risks than traditional open surgery. Additionally, technological advancements in the field have improved the accuracy and effectiveness of the procedure. Some companies in the ESWL market include Storz Medical, Siemens Healthineers, and Dornier MedTech. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.